Cytokine and Lipopolysaccharide Stimulation of Endothelin-1 Release from Human Internal Mammary Artery and Saphenous Vein Smooth-Muscle Cells
- 1 January 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 31, S348-S350
- https://doi.org/10.1097/00005344-199800001-00097
Abstract
Many pathologic conditions are associated with elevations in the production of endothelin-1 (ET-1) in the blood vessel wall. Because many of these conditions are cytokine-driven we examined the effects of a mixture of cytokines and lipopolysaccharide on ET-1 production in human vascular smooth-muscle (VSMC) cells derived from the internal mammary artery (IMA) and saphenous vein (SV). Incubation of VSMCs from IMA and SV with a combination of tumor necrosis factor-alpha (10 ng/ml), interferon-gamma (1,000 U/ml), interleukin-1 beta (500 U/ml) and lipopolysaccharide (10 micrograms/ml) for up to 48 h markedly elevated the expression of mRNA for ET-1 and the release of ET-1 into the culture medium. We conclude that low levels of ET-1 mRNA and peptide production in human VSMCs are markedly increased by exposure to cytokines and LPS. This suggests that during inflammatory states the VSMC, as well as the endothelium, may be a site of significant ET-1 production in the blood vessel wall.Keywords
This publication has 12 references indexed in Scilit:
- Secretion of endothelin‐1 and endothelin‐3 by human cultured vascular smooth muscle cellsBritish Journal of Pharmacology, 1995
- Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromesThe Lancet, 1994
- Endothelin receptor antagonists: Actions and rationale for their developmentBiochemical Pharmacology, 1994
- The structure and specificity of endothelin receptors: Their importance in physiology and medicinePharmacology & Therapeutics, 1993
- Production of Endothelin by Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1991
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences, 1989
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976